Provectus Biopharmaceuticals, Inc. Stock
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
12:49:44 07/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.0531 USD | -0.09% |
|
-7.01% | -5.01% |
| Market Cap | 22.34M 19.93M 18.57M 16.9M 31.82M 2.15B 32.05M 224M 87.28M 1.1B 83.86M 82.05M 3.53B | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 25.07M 22.36M 20.83M 18.96M 35.7M 2.41B 35.97M 252M 97.94M 1.23B 94.1M 92.06M 3.96B | EV / Sales 2024 |
86,451,912x | EV / Sales 2025 | 78,013,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| 1 day | -0.09% | ||
| 1 week | -7.01% | ||
| Current month | -7.01% | ||
| 3 months | -22.82% | ||
| 6 months | +6.84% | ||
| Current year | -5.01% |
| 1 week | 0.05 |  | 0.06 |
| 1 month | 0.05 | | 0.06 |
| Current year | 0.04 | | 0.08 |
| 1 year | 0.04 | | 0.08 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 16/04/2024 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/05/2012 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 25/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 03/04/2017 | |
John Lacey
BRD | Director/Board Member | 78 | 27/04/2018 |
Edward Pershing
CHM | Chairman | 73 | 27/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/10/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 18/9/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 11/9/26 | Exercice | Chief Executive Officer | -13,216 | 0.1400% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | -7.01% | -37.42% | -36.10% | 22.34M | |
| +4.16% | +3.42% | +49.37% | +94.17% | 74.31B | |
| +2.76% | -1.60% | +22.80% | +78.53% | 56.95B | |
| +0.24% | -1.34% | +3.41% | +34.31% | 48.3B | |
| -3.33% | -1.64% | +331.81% | +703.25% | 44.51B | |
| -0.54% | -1.47% | +29.27% | +33.42% | 43.8B | |
| +1.09% | +0.70% | +6.76% | +111.54% | 41.12B | |
| -0.11% | +2.30% | +9.19% | +58.68% | 31.07B | |
| +4.51% | +8.43% | +37.27% | +34.97% | 28.97B | |
| +0.05% | -0.66% | -6.88% | -11.95% | 24.53B | |
| Average | +0.89% | -0.89% | +44.56% | +110.08% | 39.36B | |
| Weighted average by Cap. | +1.23% | -0.50% | +57.57% | +134.72% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.55 0.51 0.47 0.88 59.43 0.89 6.2 2.41 30.33 2.32 2.27 97.51 | 0.34 0.3 0.28 0.25 0.48 32.37 0.48 3.38 1.31 16.52 1.26 1.23 53.1 |
| Net income | -4.76M -4.25M -3.96M -3.6M -6.78M -459M -6.83M -47.82M -18.61M -234M -17.88M -17.49M -752M | -5.43M -4.84M -4.51M -4.11M -7.74M -523M -7.79M -54.54M -21.22M -267M -20.39M -19.95M -858M |
| Net Debt | 2.88M 2.57M 2.39M 2.18M 4.1M 277M 4.13M 28.9M 11.24M 141M 10.8M 10.57M 455M | 2.73M 2.43M 2.27M 2.06M 3.88M 263M 3.91M 27.39M 10.66M 134M 10.24M 10.02M 431M |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/10/26 | USD 0.0531 | -0.09% | 31,935 |
| 05/10/26 | USD 0.0532 | -2.30% | 10,732 |
| 02/10/26 | USD 0.0544 | 0.00% | 15,072 |
| 01/10/26 | USD 0.0544 | -4.73% | 425,782 |
| 30/09/26 | USD 0.0571 | 0.00% | 5,300 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
